Overview Brain arteriovenous malformations (bAVMs) are an important cause of intracranial hemorrhage (ICH) in young adults. Treatment is invasive and controversy remains over the clinical management of unruptured bAVMs. Robust prognostic and monitoring biomarkers are completely lacking, which are critically needed for future clinical trials of anti-angiogenic or anti-inflammatory therapies. Emerging data suggests that epigenetic mechanisms, such as DNA methylation regulating gene expression, play a role in cerebrovascular disease, yet comprehensive epigenomic studies in bAVM have not been performed. Blood epigenetic profiling poses a novel direction to identify epigenetic signatures that differentiate those at risk for ICH. In this project, we are utilizing whole methylome sequencing and methylome arrays to identify blood epigenetic signatures in bAVM patients that reveal novel prognostic or monitoring biomarkers (genes) and point to new therapeutic targets for hemorrhage and high risk features. Using this approach, we are also studying whether blood epigenetic signatures can be used to differentiate bAVMs that harbor somatic mutations. These studies capitalize on the large UCSF Brain AVM Project cohort (PI: Helen Kim) with detailed clinical and genetic data and banked specimens which began in 2000. Affiliated Lab Center for Cerebrovascular Research Principal investigator UCSF Shantel Weinsheimer, PhD Assistant Adjunct Professor Helen Kim, MPH, PhD Professor in Residence Seeking collaborators We are interested in collaborating with investigators that use molecular profiling techniques to identify biomarkers for cerebrovascular disease phenotypes. Email Us Support this research We are interested in donations to support our research efforts related to the identification of non-invasive molecular biomarkers for cerebrovascular disease. Support
Center for Cerebrovascular Research Reduction of brain AVM severity through inhibition of pathogenic angiogenesis
Center for Cerebrovascular Research Cellular loci involved in the pathogenesis of brain arteriovenous malformations
Center for Cerebrovascular Research Detection of somatic mutations in cerebral cavernous malformation patients using non-invasive cell-free DNA screening
Center for Cerebrovascular Research Modifiers of disease severity and progression in familial cerebral cavernous malformation (BVMC 6201)
Center for Cerebrovascular Research Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)
Center for Cerebrovascular Research Investigating disparities and barriers in access to research and care for patients with Hereditary Hemorrhagic Telangiectasia (HHT)
Center for Cerebrovascular Research Integrated longitudinal studies to identify biomarkers and therapeutic strategies for Sturge-Weber Syndrome (BVMC 6211)
Center for Cerebrovascular Research IL-6 trans-signaling increases risk for perioperative neurocognitive disorders in aging and neurodegenerative diseases
Center for Cerebrovascular Research Cerebral hemorrhage risk in hereditary hemorrhagic telangiectasia (BVMC 6203)
Center for Cerebrovascular Research Predictors of growth, recurrence, and high-risk features in pediatric brain arteriovenous malformation (project 1)